Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.25NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.79NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HP.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FU.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.3.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EY.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.35NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EL.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.44NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FU.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EF.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.84NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EU.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.97NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FE.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.3.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.95NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
ET.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.34NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.31NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.3.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.47NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.58NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GH.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.2.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.96NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EZ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CM.8.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GD.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBZNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BR.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.79NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FD.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CM.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used